Understanding how steroids work in airway muscles for asthma
Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle
This work explores how steroid medications change genes in the airway muscles of people with asthma to help improve treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | National Jewish Health NIH-funded |
| Lab location | 1 site (Denver, United States) |
| Project ID | NIH-11044059 on NIH RePORTER |
What this research studies
Steroid medications, known as glucocorticoids, are very effective for controlling asthma and reducing inflammation in the airways. While inhaled steroids help most patients, some still experience severe asthma and frequent flare-ups, requiring stronger treatments with more side effects. This project looks closely at how these steroids interact with cells in the airway smooth muscle, a key area affected by asthma. By understanding the specific ways steroids turn genes on or off, we hope to find new and better ways to treat asthma, especially for those who don't respond well to current therapies. This approach focuses on a different understanding of how steroids work compared to previous ideas.
Who could benefit from this research
Good fit: This foundational work is for patients with asthma, especially those who struggle with current steroid treatments or experience frequent asthma exacerbations.
Not a fit: Patients without asthma or those whose asthma is well-controlled with existing therapies may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new and more effective asthma medications with fewer side effects, particularly for patients with difficult-to-control asthma.
How similar studies have performed: While steroids are a well-established treatment, this work explores a novel understanding of their mechanisms, moving beyond previous models to find new therapeutic targets.
Where this research is happening
Denver, United States
- National Jewish Health — Denver, United States (Active)
Researchers
- Principal investigator: Gerber, Anthony N — National Jewish Health
- Study coordinator: Gerber, Anthony N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.